Skip to main content

Monsanto’s Summary Judgment Motion Rejected By MDL Judge

Monsanto’s Summary Judgment Motion Rejected By MDL Judge

Monsanto’s Summary Judgment Motion Rejected By MDL Judge

Introduction

In a pretrial order issued on March 7, U.S. District Judge Vince Chhabria rejected a motion for summary judgment filed by Monsanto to escape a series of bellwether cases lined up against it over the hazards of the controversial weed killer, Roundup.

Judge Chhabria indicated that the claims filed against Monsanto would continue and the agro-giant must bear punitive damages if the plaintiffs successfully prove that glyphosate exposure from Roundup herbicide caused their cancer. The judge opined, if the plaintiffs establish the causation, Monsanto will be liable for withholding safety warnings. Judge Chhabria further stated, "although the evidence that Roundup causes cancer is quite equivocal, there is strong evidence from which a jury could conclude that Monsanto does not particularly care whether its product is, in fact, giving people cancer, focusing instead on manipulating public opinion and undermining anyone who raises genuine and legitimate concerns about the issue.” The judge rejected Monsanto's arguments that the evidence presented was insufficient to support a punitive damages award.

The federal bellwether trial developments over glyphosate exposure and cancer are closely observed by other plaintiffs and lawyers, as Monsanto is charged with more than 10,000 other Roundup lawsuits over allegations that it failed to take adequate measures to forewarn about glyphosate exposure risks.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!